Working Group 6: How do the gut, immune system and brain interact to influence cognition, mood and mental health?
How do the gut, immune system and brain interact to influence cognition, mood and mental health?
Investigating the links between the Gut-Immune-Brain Axis and cognition, mood and mental health across the lifecourse.
The Gut-Immune-Brain Axis (GIBA) is a complex communication network linking gut microbes, the immune system, and the brain. Emerging research shows that signals exchanged between these systems influence emotional and cognitive processes. The immune system plays a central role in translating signals from the gut microbiome to the brain, shaping inflammation, stress responses, and neural function. When gut, immune, or brain barriers become compromised, chronic inflammation can disrupt neural circuits involved in memory, mood, and behaviour. Our working group brings together researchers from across the GIBA Network to build capacity and foster collaboration in understanding the mechanistic pathways through which gut microbes, immune responses, and brain function interact to regulate cognition, stress resilience, and mental health, and how these processes influence vulnerability to conditions such as anxiety, depression, and neurodegenerative health. Join us for our monthly discussion forum.
Working Group Leads
Lewis Hepburn
Doctoral Researcher at Leeds Beckett University
Lewis is a doctoral researcher at Leeds Beckett University, working across the Human Behavioural Neuroscience Lab and the Carnegie School of Sport.
Lewis’s research investigates the relationship between cognitive and metabolic health, with a particular focus on sleep, nutrition, and the gut–microbiome–brain axis. He is especially interested in how metabolic disorders such as diabetes influence cognitive processes, behaviour, and susceptibility to adverse health outcomes. His current doctoral project involves designing and leading a randomized, double-blind, placebo-controlled clinical trial to evaluate whether probiotic supplementation can enhance cognition, cerebral haemodynamics, and cardiometabolic health in overweight individuals with impaired glucose tolerance.
Ashley Bell
Post-Doctoral Researcher at Imperial College London
Ashley is a postdoctoral researcher at Imperial College London studying how microbiomes influence health and disease.
He works as a bioinformatician and molecular biologist, using genomic, transcriptomic, proteomic, and metabolomic data to study microbiome function. He is currently part of the EU-funded GEMMA project, applying multi-omics methods to identify biomarkers linked to autism spectrum disorder. His PhD at the University of Exeter focused on microbiome responses to environmental stress, antibiotic exposure, and host-specific effects, including antimicrobial resistance in aquaculture systems. He has also worked on marine and open-ocean microbiomes and has a strong interest in teaching and training.
Allisha Beckett
Doctoral Researcher at the University of Reading
More Info
Allisha Beckett
Doctoral Researcher at the University of Reading
Allisha is a doctoral researcher at the University of Reading, studying the interaction between vitamin D and the gut microbiome.
Her research investigates how modulation of the gut microbiome may influence vitamin D absorption and status. She is particularly interested in the potential role of the gut–brain axis and the relationship between vitamin D status and mental health, including depression. Her current doctoral research involves designing a randomised, double-blind, placebo-controlled clinical trial to investigate whether prebiotic or probiotic supplementation can improve vitamin D status beyond vitamin D supplementation alone.
Jessica Teeling
Co-Lead of the GIBA Network+
Jessica Teeling is a Professor of Experimental Neuroimmunology at the University of Southampton.
She leads a dynamic research group exploring how systemic inflammation, including gut infections, affects brain function. Her team integrates in vivo models and human cohort studies to investigate neuroinflammation in dementia, aiming to develop innovative therapeutic strategies and identify diagnostic and prognostic biomarkers.
Her research is supported by UK Research and Innovation, Alzheimer’s Research UK, Alzheimer’s Society, the Lewy Body Society, and industry partners.